The Association of Independent Research Institutes named OMRF Vice President and Chief Financial Officer Tim Hassen as its new president.
The findings will help push clinicians closer to personalized medicine for lupus sufferers.
The new funding will support investigations into cellular mutations linked to rare skeletal diseases and vessel function.
OMRF’s findings could lead to new strategies to combat age-related muscle loss.
The award-winning Multiple Sclerosis Center of Excellence at OMRF is one of the preeminent MS research and treatment centers in the world.
Scientists have long known lupus has a strong genetic component, but there also must be environmental triggers to activate the disease.